Franklin Genomic Advancements ETF · Other
3m RS is unavailable, Market Stance is 49.9
As of 2026-08-21, Franklin Genomic Advancements ETF (HELX) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 49.9 (Neutral). Sector: Other. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | GH | 6.77% | $1M |
| 2 | NTRA | 6.65% | $1M |
| 3 | KRYS | 5.32% | $1M |
| 4 | UTHR | 4.64% | $996K |
| 5 | INSM | 4.52% | $970K |
| 6 | BBIO | 4.22% | $905K |
| 7 | LGND | 3.53% | $757K |
| 8 | AZN | 3.40% | $729K |
| 9 | ADPT | 3.12% | $670K |
| 10 | VRTX | 2.99% | $641K |
| 11 | MEDP | 2.97% | $637K |
| 12 | REGN | 2.69% | $578K |
| 13 | CTVA | 2.69% | $578K |
| 14 | ALNY | 2.60% | $558K |
| 15 | LLY | 2.54% | $545K |
| 16 | IONS | 2.09% | $447K |
| 17 | TEM | 1.84% | $395K |
| 18 | BNTX | 1.80% | $386K |
| 19 | NBIX | 1.65% | $355K |
| 20 | STOK | 1.60% | $343K |
| 21 | TWST | 1.59% | $341K |
| 22 | PTCT | 1.48% | $317K |
| 23 | TVTX | 1.40% | $301K |
| 24 | CRL | 1.16% | $249K |
| 25 | RGEN | 1.03% | $220K |
Showing 25 of 51 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HELX Jan avg: 2.49% median: 2.92% win: 75% σ: 4.09% n: 4 2022-04-12 → 2026-07-31 | HELX Feb avg: -2.06% median: -4.98% win: 25% σ: 6.74% n: 4 2022-04-12 → 2026-07-31 | HELX Mar avg: -2.02% median: -1.23% win: 50% σ: 4.83% n: 4 2022-04-12 → 2026-07-31 | HELX Apr avg: -3.56% median: -1.77% win: 40% σ: 5.10% n: 5 2022-04-12 → 2026-07-31 | HELX May avg: 1.15% median: 2.46% win: 60% σ: 4.26% n: 5 2022-04-12 → 2026-07-31 | HELX Jun avg: 4.07% median: 2.42% win: 80% σ: 6.25% n: 5 2022-04-12 → 2026-07-31 | HELX Jul avg: 3.50% median: 3.31% win: 80% σ: 5.19% n: 5 2022-04-12 → 2026-07-31 | HELX Aug avg: -1.12% median: -1.25% win: 25% σ: 6.88% n: 4 2022-04-12 → 2026-07-31 (current) | HELX Sep avg: -3.62% median: -5.10% win: 25% σ: 5.43% n: 4 2022-04-12 → 2026-07-31 | HELX Oct avg: 0.35% median: -1.23% win: 50% σ: 10.92% n: 4 2022-04-12 → 2026-07-31 | HELX Nov avg: 5.80% median: 5.63% win: 100% σ: 3.33% n: 4 2022-04-12 → 2026-07-31 | HELX Dec avg: -1.98% median: -5.16% win: 25% σ: 7.62% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 50 tickers across 51 holdings rows (87.7% of fund weight). Metrics as of 2026-08-21; holdings from the filing.
Holdings of HELX currently on TickerStance stock-RS leaderboards.